
Metabolic research compound — 50 mg tablets.
5-Amino-1MQ is a small-molecule NNMT inhibitor studied in metabolic research. The box lists 50 mg per tablet, 50 tablets per box.
It is designed to inhibit nicotinamide N-methyltransferase (NNMT), an enzyme linked in preclinical work to fat-cell metabolism and NAD+ balance.
Human safety data are limited. Not for use in pregnancy or breastfeeding, or by anyone under 18.
Follow the label on the box and discuss use with a qualified healthcare professional before starting. No dose is suggested here.
Follow the label on the box. Keep sealed, cool, dry and out of direct light and out of children’s reach. Ask for advice after any temperature excursion.
50 tablets of 50 mg, as listed on the box.
Do not self-stack research compounds, stimulants or hormone-active products. Ask a qualified clinician to review ingredients, medicines, medical history and monitoring requirements.
Contact Peak Protocol for the current batch’s identity, strength and purity documentation. No universal purity percentage or accreditation is assumed.
Contact us within 2 days with photo or video evidence. No product refunds: approved returns are for store credit only after inspection. Return courier costs are paid by the client. See the full returns policy.